The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Open accessAbstract
Although amyloid deposition was noted by Alzheimer in 1907 (1Alzheimer A. Stelzmann R.A. Schnitzlein H.N. Murtagh F.R. Clin. Anat. 1995; 8: 429-431Crossref PubMed Scopus (775) Google Scholar), it has been only 17 years since the toxicity of Aβ 2The abbreviations used are: Aβ, amyloid β-protein; AD, Alzheimer disease; APP, amyloid precursor protein; NFTs, neurofibrillary tangles; FAD, familial AD; ADDLs, Aβ-derived diffusible ligands; LTD, long-term depression; MAPK, mitogen-activated protein kinase; NMDA, N-methyl-d-aspartate; GABA, γ-aminobutyric acid. was first described (2Yankner B.A. Duffy L.K. Kirschner D.A. Science. 1990; 250: 279-282Crossref PubMed Scopus (1917) Google Scholar). The prevailing view through most of the twentieth century was that Aβ is a marker of disease progression in AD but does not play a role in the neurodegenerative process. This view changed in the 1990s with the articulation of the amyloid hypothesis, which posits that abnormal accumulation of Aβ in the brain is a direct cause of neurodegeneration and cognitive decline in AD. The hypothesis is supported by the identification of mutations in APP (3Goate A. Chartier-Harlin M.C. Mullan M. Brown J. Crawford F. Fidani L. Giuffra L. Haynes A. Irving N. James L. Mant R. Newton P. Rooke K. Roques P. Talbot C. Nature. 1991; 349: 704-706Crossref PubMed Scopus (3811) Google Scholar) and presenilins 1 and 2 (4Sherrington R. Rogaev E.I. Liang Y. Rogaeva E.A. Levesque G. Ikeda M. Chi H. Lin C. Li G. Holman K. Tsuda T. Mar L. Foncin J.-F. Bruni A.C. Montesi M.P. Nature. 1995; 375: 754-760Crossref PubMed Scopus (3599) Google Scholar, 5Levy-Lahad E. Wasco W. Poorkaj P. Romano D.M. Oshima J. Pettingell W.H. Yu C.E. Jondro P.D. Schmidt S.D. Wang K. Crowley A.C. Fu Y.-H. Guenette S.Y. Galas D. Nemens E. Science. 1995; 269: 973-977Crossref PubMed Scopus (2241) Google Scholar, 6Rogaev E.I. Sherrington R. Rogaeva E.A. Levesque G. Ikeda M. Liang Y. Chi H. Lin C. Holman K. Tsuda T. Mar L. Sorbi S. Nacmias B. Piacentini S. Amaducci L. Nature. 1995; 376: 775-778Crossref PubMed Scopus (1801) Google Scholar, 7Li J. Ma J. Potter H. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 12180-12184Crossref PubMed Scopus (50) Google Scholar) that increase Aβ generation or, more importantly, the generation of a minor 42-amino acid form (Aβ42) with an increased propensity for aggregation (8Suzuki N. Cheung T.T. Cai X.D. Odaka A. Otvos Jr., L. Eckman C. Golde T.E. Younkin S.G. Science. 1994; 264: 1336-1340Crossref PubMed Scopus (1358) Google Scholar). This review sets forth the major lines of evidence for Aβ toxicity and focuses on the interface between Aβ toxicity and molecular mechanisms of synaptic plasticity. The early studies of Blessed and co-workers (9Roth M. Tomlinson B.E. Blessed G. Nature. 1966; 209: 109-110Crossref PubMed Scopus (224) Google Scholar) suggested that plaque numbers were directly related to quantitative measures of cognitive decline in the aged population. However, subsequent studies carried out by Terry et al. (10Terry R.D. Masliah E. Salmon D.P. Butters N. DeTeresa R. Hill R. Hansen L.A. Katzman R. Ann. Neurol. 1991; 30: 572-580Crossref PubMed Scopus (3423) Google Scholar) cast doubt on the predictive value of plaque numbers, suggesting instead that NFTs and synapse loss were more reliable predictors of cognitive decline. Moreover, plaque formation is a common feature of the aging human brain that can occur in the absence of cognitive decline (11Yankner B.A. Lu T. Loerch P. Annu. Rev. Pathol. 2008; 3: 41-66Crossref PubMed Scopus (473) Google Scholar). More recently, it has been suggested that accumulation of toxic oligomers of Aβ may be more relevant than plaques to mechanisms involved in cognitive decline. Transgenic mouse models expressing APP and presenilin variants associated with FAD have provided important insights into structural, neurophysiological, and behavioral effects of Aβ accumulation in the brain (12Morrissette D.A. Parachikova A. Green K.N. LaFerla F.M. J. Biol. Chem. 2009; 284 (in press)Abstract Full Text Full Text PDF PubMed Scopus (143) Google Scholar). Multiphoton imaging studies have demonstrated disrupted neurites and decreased spine density in association with fibrillar Aβ deposits in the Tg2576 transgenic mouse model that expresses the APPsw mutation (13Knowles R.B. Wyart C. Buldyrev S.V. Cruz L. Urbanc B. Hasselmo M.E. Stanley H.E. Hyman B.T. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 5274-5279Crossref PubMed Scopus (206) Google Scholar, 14Spires T.L. Meyer-Luehmann M. Stern E.A. McLean P.J. Skoch J. Nguyen P.T. Bacskai B.J. Hyman B.T. J. Neurosci. 2005; 25: 7278-7287Crossref PubMed Scopus (477) Google Scholar). In addition, stereologic mapping of neuronal cell density showed some degree of neuronal loss in the immediate vicinity of Aβ deposits (15Urbanc B. Cruz L. Le R. Sanders J. Ashe K.H. Duff K. Stanley H.E. Irizarry M.C. Hyman B.T. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 13990-13995Crossref PubMed Scopus (188) Google
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Cited by
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
The Amyloid State of Proteins in Human Diseases
Eisenberg, D., & Jucker, M. (2012) · Cell · doi:10.1016/j.cell.2012.02.022 · Cited by 1,744
Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue
Lu, J.-X., Qiang, W., Yau, W.-M., Schwieters, C. D., Meredith, S. C., & Tycko, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.035 · Cited by 1,097
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
Multi-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition
Martorell, A. J., Paulson, A. L., Suk, H.-J., Abdurrob, F., Drummond, G. T., Guan, W., Young, J. Z., Kim, D. N.-W., Kritskiy, O., Barker, S. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.014 · Cited by 798
Metadata
- Authors
- Yankner, B. A., & Lu, T.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 284
- Issue
- 8
- Pages
- 4755-4759
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2079031778
- Cited by
- 227
- References
- 42
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease. https://app.cochat.ai/papers/10.1074/jbc.r800018200
- The paper
- Yankner, B. A., & Lu, T. (2009). Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r800018200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.